KRRO today
$14.41-$1.32 (-8.39%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourBearish
1 hourStrong Bearish
15 minStrong Bearish
5 minExpanding
Daily trend turns up above $15.55
Key levels
Resistance$16.86
Resistance$15.15
Support$13.76
Support$12.38
Latest news & SEC filings
DealNovo Nordisk ends research collaboration with Korro Bio
EarningsKorro Bio Posts Q3 2026 Financials
EarningsKorro Bio posts smaller quarterly loss than expected
SEC FilingKorro Bio, Inc. filed a report on a major company event (Form 8-K)
All KRRO news →About Korro Bio
Korro Bio is a biopharmaceutical company that creates therapies by editing RNA rather than DNA. Its pipeline targets high ammonia levels, a inherited liver and lung disorder, metabolic and liver conditions tied to aging, and ALS, using its own oligonucleotide platform. It also works with Novo Nordisk under a collaboration that is currently paused.
Based on the company's 10-K filed Mar 12, 2026.
Nasdaq · Healthcare
Korro Bio, Inc. (KRRO)
What Is the Price Target for KRRO?
SEPT Low Target
$15.00
SEPT Mid Target
$15.00
SEPT High Target
$21.00
Analyst Consensus
$15.00
Is KRRO a Buy or Sell Right Now?
Thesis
- •Revenue growing 181.5% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for KRRO.
Start Free Trial →Is KRRO Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
Analyst Consensus
Fair Value
$15.00
19
Moat Score
NONE
2/9
Piotroski Score
-6.0
Altman Z-Score
What Is Smart Money Doing with KRRO?
Insider Signal
NEUTRAL
8 buys / 9 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| FORMELA JEAN FRANCOIS | director | Sale | 31,888 | $450K | Sep 14, 2026 |
| FORMELA JEAN FRANCOIS | director | Sale | 6,602 | $93K | Sep 14, 2026 |
| FORMELA JEAN FRANCOIS | director | Sale | 8,450 | $118K | Sep 11, 2026 |
| FORMELA JEAN FRANCOIS | director | Sale | 1,750 | $24K | Sep 11, 2026 |
| FORMELA JEAN FRANCOIS | director | Sale | 249 | $3K | Aug 26, 2026 |
| FORMELA JEAN FRANCOIS | director | Sale | 51 | $711.96 | Aug 26, 2026 |
| Aiyar Ram | director officer | Sale | 15,152 | $197K | May 29, 2026 |
| FORMELA JEAN FRANCOIS | director | Sale | 2,441 | $34K | May 28, 2026 |
| FORMELA JEAN FRANCOIS | director | Sale | 419 | $6K | May 28, 2026 |
| Aiyar Ram | director officer | Buy | 50,000 | $617K | May 26, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →KRRO Growth Story
Revenue YoY
181.5%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-33.19%
FCF Growth YoY
-1.4%
Revenue Trend
ACCELERATING
Dark Pool Trades for KRRO
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for KRRO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:28:50 | $15.36 | 1,000 | $$15K | SELL |
| 18:05:20 | $15.47 | 3,316 | $$51K | SELL |
| 17:12:13 | $15.67 | 2,000 | $$31K | BUY |
| 16:33:06 | $15.20 | 3,845 | $$58K | BUY |
| 16:00:43 | $15.17 | 2,000 | $$30K | SELL |
5 dark pool trades shown · $$187K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Korro Bio, Inc. (KRRO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →KRRO — frequently asked questions
What is KRRO stock price today?
Korro Bio, Inc. (KRRO) is at $14.41, down 8.39% (-$1.32) at the Nov 11, 2026 close.
Why is KRRO stock moving today?
Latest KRRO news — Nov 5, 2026: Novo Nordisk ends research collaboration with Korro Bio · Nov 5, 2026: Korro Bio Posts Q3 2026 Financials
What is the KRRO price target?
The average analyst price target for KRRO is $15.00, ranging from $15 to $21, based on 3 analysts.
What do analysts rate KRRO?
Analyst ratings for KRRO: 0 Buy, 4 Hold, 0 Sell — consensus Hold.
Did KRRO beat earnings?
KRRO last reported on Aug 6, 2026: EPS -$1.07 vs -$1.34 expected — a beat of 20.1%.
Does KRRO pay a dividend?
KRRO does not currently pay a dividend.
What are KRRO support and resistance levels?
Support: $13.76, $12.38, $9.78. Resistance: $15.15, $16.86, $18.52.
What are insiders doing with KRRO?
Insider activity: NEUTRAL, 8 buys and 9 sells in the last 90 days.
What is the latest news on KRRO?
Nov 5, 2026: Novo Nordisk ends research collaboration with Korro Bio · Nov 5, 2026: Korro Bio Posts Q3 2026 Financials · Nov 5, 2026: Korro Bio posts smaller quarterly loss than expected